Clincosm LogoSign in Get a demo

Breast Cancer

Showing NaN - NaN of 167
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Trial in Worldwide (Ribociclib, Letrozole, Goserelin)

Active, not recruiting
Has Results
  • Breast Cancer
  • Anchorage, Alaska
  • +495 more
Jun 15, 2022

Breast Tumors, Breast Cancer, Estrogen-receptor Positive Breast Cancer Trial in France, United Kingdom, United States (H3B-6545)

Active, not recruiting
  • Breast Neoplasms
  • +7 more
  • Goodyear, Arizona
  • +38 more
Jun 29, 2022

Breast Cancer, Triple Negative Breast Cancer, Residual Cancer Trial in United States (Atezolizumab, Sacituzumab govitecan)

Recruiting
  • Breast Cancer
  • +3 more
  • San Francisco, California
  • +8 more
May 25, 2022

Breast Cancer Trial in Worldwide (Amcenestrant-matching , SAR439859, Palbociclib)

Active, not recruiting
  • Breast Cancer
  • Amcenestrant-matching placebo
  • +5 more
  • Daphne, Alabama
  • +299 more
May 5, 2022

Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan (T-DXd), Ado-trastuzumab emtansine (T-DM1))

Active, not recruiting
Has Results
  • Breast Cancer
  • Trastuzumab deruxtecan (T-DXd)
  • Ado-trastuzumab emtansine (T-DM1)
  • Los Angeles, California
  • +163 more
Apr 1, 2022

Breast Cancer Trial in Ireland, United States (bevacizumab, docetaxel, doxorubicin)

Completed
  • Breast Cancer
  • Bessemer, Alabama
  • +532 more
Apr 13, 2022

Breast Cancer Trial in Worldwide (Palbociclib, Standard Adjuvant Endocrine Therapy)

Active, not recruiting
Has Results
  • Breast Cancer
  • Mobile, Alabama
  • +437 more
Mar 21, 2022

Colorectal Cancer (CRC), Endometrial Cancer, Melanoma Trial in United States (Pembrolizumab, itacitinib, INCB050465)

Completed
  • Colorectal Cancer (CRC)
  • +10 more
  • San Francisco, California
  • +16 more
Mar 30, 2022

Breast Cancer Trial in United States (Trastuzumab, Paclitaxel, Trastuzumab emtansine)

Active, not recruiting
Has Results
  • Breast Cancer
  • Birmingham, Alabama
  • +84 more
Mar 15, 2022

Breast Cancer Trial in United States (Palbociclib, Aromatase Inhibitor)

Completed
Has Results
  • Breast Cancer
  • San Francisco, California
  • +9 more
Mar 18, 2022

Malignancy, Non-hodgkin Lymphoma, Multiple Myeloma Trial in United States (CYT-0851, CYT-0851 in combination with gemcitabine,

Recruiting
  • Malignancy
  • +14 more
  • Scottsdale, Arizona
  • +17 more
Mar 7, 2022

Breast Cancer, Breast Cancer Female, Genetic Predisposition to Disease Trial in San Francisco (Cephalexin)

Recruiting
  • Breast Cancer
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Feb 22, 2022

Breast Cancer Trial in Worldwide (LEE011, Letrozole, BYL719)

Active, not recruiting
  • Breast Cancer
  • San Diego, California
  • +23 more
Feb 17, 2022

Risk Reduction, Breast Cancer Trial in United States (Bazedoxifene and Conjugated Estrogens)

Recruiting
  • Risk Reduction
  • Breast Cancer
  • Bazedoxifene and Conjugated Estrogens
  • Duarte, California
  • +4 more
Feb 14, 2022

Breast Cancer Trial in United States (Margetuximab)

Completed
Has Results
  • Breast Cancer
  • Margetuximab
  • San Francisco, California
  • +5 more
Feb 4, 2022

Mesothelioma, Bladder Cancer, Melanoma Trial in Australia, Canada, United States (MGD009)

Terminated
  • Mesothelioma
  • +12 more
  • MGD009
  • Los Angeles, California
  • +19 more
Feb 4, 2022

Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan (DS-8201a), Capecitabine, Eribulin)

Active, not recruiting
  • Breast Cancer
  • Trastuzumab deruxtecan (DS-8201a)
  • +5 more
  • Chandler, Arizona
  • +207 more
Jan 25, 2022

Breast Cancer Trial in Worldwide (Abemaciclib, Standard Adjuvant Endocrine Therapy)

Active, not recruiting
Has Results
  • Breast Cancer
  • Birmingham, Alabama
  • +611 more
Jan 21, 2022

Breast Cancer Trial in Canada, Puerto Rico, United States (pegfilgrastim, AC regimen, cyclophosphamide)

Active, not recruiting
Has Results
  • Breast Cancer
  • pegfilgrastim
  • +4 more
  • Anniston, Alabama
  • +541 more
Jan 19, 2022

Cholangiocarcinoma, Urothelial Cancer, Advanced and Metastatic Cancer Patients With Tumors Harboring FGF/FGFR Tumors Trial in

Active, not recruiting
  • Cholangiocarcinoma
  • +5 more
  • Gilbert, Arizona
  • +57 more
Jan 5, 2022

Breast Cancer, Colorectal Cancer Trial in United States (Telephone-Based exercise intervention)

Active, not recruiting
  • Breast Cancer
  • Colorectal Cancer
  • Telephone-Based exercise intervention
  • La Jolla, California
  • +8 more
Jan 5, 2022

Breast Cancer Trial in United States (Radiation Therapy)

Active, not recruiting
  • Breast Cancer
  • Radiation Therapy
  • San Francisco, California
  • +14 more
Jan 3, 2022

Contrast-Enhanced MRI for Characterization of Ductal Carcinoma

Recruiting
  • Breast Cancer
  • contrast-enhanced magnetic resonance imaging
  • Gadavist
  • San Francisco, California
    University of California, San Francisco
Nov 30, 2021

Breast Cancer Trial in United States (Screening digital mammography, Screening digital breast tomosynthesis, Screening breast

Active, not recruiting
  • Breast Cancer
  • Screening digital mammography
  • +4 more
  • Davis, California
  • +6 more
Nov 16, 2021

Breast Cancer Screening, Breast Carcinoma in Situ, Breast Cancer Trial in United States (Complete a health questionnaire,

Recruiting
  • Breast Cancer Screening
  • +2 more
  • Complete a health questionnaire
  • +3 more
  • Birmingham, Alabama
  • +9 more
Nov 8, 2021